✦ LIBER ✦

Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan - A randomised proof-of-concept trial

✍ Scribed by Ferrari, M. D.; Farkkila, M.; Reuter, U.; Pilgrim, A.; Davis, C.; Krauss, M.; Diener, H.-C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Selective seratonin 1F (5-HT1F) receptor

✍ DJ Goldstein; KI Roon; WW Offen; NM Ramadan; LA Phebus; KW Johnson; JM Schaus; M 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 85 KB

Efficacy and tolerability of lasmiditan,

✍ Markus Färkkilä; Hans-Christoph Diener; Gilles Géraud; Miguel Láinez; Jean Schoe 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 242 KB

The 5-HT1Freceptor agonist lasmiditan as

✍ Tfelt-Hansen, Peer C.; Olesen, Jes 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 223 KB

The development of a highly selective 5-

✍ Dr. Wasyl Feniuk; Patrick P. A. Humphrey 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 1 views

POSSIBLE BENEFIT OF GR43175, A NOVEL 5-H

✍ Doenicke, Alfred; Brand, Jochen; Perrin, ValL. 📂 Article 📅 1988 🏛 The Lancet 🌐 English ⚖ 443 KB

Cranial vascular effects of zolmitriptan

✍ Stephen J. MacLennan; David Cambridge; Mark V. Whiting; Chris Marston; Graeme R. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 208 KB